Comparison Between Gamma 3 Nail and ACE Trochanteric Nail

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2013 by University Hospital, Ghent
Sponsor:
Information provided by (Responsible Party):
University Hospital, Ghent
ClinicalTrials.gov Identifier:
NCT00367406
First received: August 21, 2006
Last updated: January 29, 2013
Last verified: January 2013

August 21, 2006
January 29, 2013
November 2006
July 2013   (final data collection date for primary outcome measure)
Consolidation of the fracture [ Time Frame: From surgery untill healing ] [ Designated as safety issue: No ]
Consolidation of the fracture
Complete list of historical versions of study NCT00367406 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Comparison Between Gamma 3 Nail and ACE Trochanteric Nail
Comparison Between Gamma 3 Nail and ACE Trochanteric Nail

Pertrochanteric and subtrochanteric femur fractures will be treated with a Gamma 3 nail or an ACE Trochanteric nail.

Following topics will be assessed: fracture consolidation, mobility, pain, walking power, agility.

Not Provided
Interventional
Not Provided
Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Pertrochanteric and Subtrochanteric Femur Fractures
Device: Gamma 3 nail versus ACE trochanteric nail
Comparing Gamma 3 nail versus ACE trochanteric nail
Experimental: Treatment with a Gamma 3 nail.
Intervention: Device: Gamma 3 nail versus ACE trochanteric nail
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
100
July 2013
July 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Pertrochanteric or subtrochanteric femur fracture
Both
18 Years and older
No
Contact: René Verdonk, MD, PhD + 32 9 332.22.64 rene.verdonk@ugent.be
Belgium
 
NCT00367406
2006/280
No
University Hospital, Ghent
University Hospital, Ghent
Not Provided
Principal Investigator: René Verdonk, MD, PhD University Hospital, Ghent
University Hospital, Ghent
January 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP